首页|中药干预治疗女性压力性尿失禁的Meta分析

中药干预治疗女性压力性尿失禁的Meta分析

扫码查看
目的:探讨中药干预治疗女性压力性尿失禁(Stress Urinary Incontinence,SUI)的临床有效率和安全性.方法:检索中国知网、维普、万方和中国生物医学文献服务系统的中文文献,PubMed、Cochrane Library、Science、Embase和 Web of Science数据库的英文文献,检索时间为建库至2022年11月10日.将纳入样本分为试验组(有中药干预组)和对照组(无中药干预组),数据分析采用RevMan 5.4.1系统.结果:共纳入16篇随机对照试验(Randomized Controlled Trial,RCT)研究文献,样本量1 227例.与对照组相比,试验组的有效率[比值比(OR)=5.09,95%置信区间(CI)(3.50,7.40),P<0.000 01]较高,尿失禁问卷表简表(ICI-Q-SF)评分[均数差(MD)=-1.47,95%CI(-1.98,-0.97),P<0.000 01]、中医证候评分[(MD=-3.36,95%CI(-5.44,-1.27),P=0.002]降低,1 h尿垫试验漏尿量[MD=-2.57,95%CI(-3.27,-1.87),P<0.000 01]、平均24 h漏尿次数[MD=-1.29,95%CI(-2.01,-0.56),P=0.000 5]减少,Ⅱ类肌肌电均值[MD=5.15,95%CI(1.03,9.28),P=0.01]、Ⅰ类肌肌电均值[MD=4.39,95%CI(2.15,6.64),P=0.000 1]、Ⅱ类肌肌电最大值[MD=7.21,95%CI(4.30,10.12),P<0.000 01]均提高,不良反应发生率[OR=0.39,95%CI(0.18,0.87),P=0.02]较低,随访结果方面,试验组的ICI-Q-SF评分[MD=-2.25,95%CI(-3.56,-0.94),P=0.000 8]、平均24 h漏尿次数[MD=-2.73,95%CI(-3.97,-1.48),P<0.000 1]均呈现出更好的结果.结论:中药干预治疗女性SUI,在现代西医治疗手段的基础上,完善中医辨证论治,为患者提供中西医结合的个体化治疗方案,有效提高临床有效率,改善中医证候评分和ICI-Q-SF评分,缓解漏尿症状,并一定程度上提高盆底肌肌力,降低不良反应的发生率,安全性良好,随访结局可观,可综合提高患者的临床疗效及生活质量,但未来仍需要大样本多中心高质量的RCT研究证据的支持.
A Meta analysis of Chinese medicine intervention for treating female stress urinary incontinence
Objective:To investigate the clinical efficacy and safety of Chinese medicine intervention in the treatment of female SUI.Methods:Chinese literature of CNKI,VIP,Wanfang,China Biomedical Literature Service System,and English literature of PubMed,Cochrane Library,Science,EMbase and Web of Science databases were searched by computer from the establishment of the databaseto November 10,2022.The included samples were divided into the experimental group(Chinese medicine intervention group)and the control group(Non-Chinese medicine intervention group).Data analysis was performed using RevMan 5.4.1 system.Results:A total of 16 RCT studies were included,with a sample size of 1 227 cases.Compared with the control group,the experimental group had a higher effective rate[OR=5.09,95%CI(3.50,7.40),P<0.000 01],and the ICI Q-SF score[MD=-1.47,95%CI(-1.98,-0.97),P<0.000 01],TCM syndrome score[MD=-3.36,95%CI(-5.44,-1.27),P=0.002]were decreased,urine leakage in 1h pad test[MD=-2.57,95%CI(-3.27,-1.87),P<0.000 01],the mean num-ber of urine leakage in 24 hours[MD=-1.29,95%CI(-2.01,-0.56),P=0.0005]decreased,the mean value of class Ⅱ[MD=5.15,95%CI(1.03,9.28),P=0.01],the mean value of class Ⅰ[MD=4.39,95%CI(2.15,6.64),P=0.0001],maximum EMG value of class Ⅱ muscles[MD=7.21,95%CI[4.30,10.12],P<0.000 01]were increased,and the incidence of adverse reactions was reduced[OR=0.39,95%CI(0.18,0.87)].In terms of follow-up results,the ICI Q-SF score[MD=-2.25,95%CI(-3.56,-0.94),P=0.0008]and the average number of urinary leakage in 24h[MD=-2.73,95%CI(-3.97,-1.48),P<0.000 1]of the experimental group showed better results.Conclusion:Based on modern Western medicine treat-ment methods,TCM intervention for female SUI improves TCM syndrome differentiation and treatment,provides patients with an individualized treatment plan combining traditional Chinese and Western medicine,effectively improves the clinical efficiency of female SUI treatment,promotes TCM syndrome score and ICI Q-SF score,alleviates urinary leakage symptoms,and improves pelvic floor muscle strength to a certain extent.The inci-dence of adverse reactions is reduced,the safety is good,the follow-up outcome is considerable,and the clinical efficacy and quality of life of patients are comprehensively improved.However,in the future,the support of large-sample,multi-center and high-quality RCT research evidence is still needed.

Female stress urinary incontinenceMeta-analysisChinese medicine treatmentEffectivenessSecurity

王纯雪、王轶蓉、王丽娜

展开 >

辽宁中医药大学,辽宁 沈阳,110000

辽宁中医药大学附属医院,辽宁 沈阳,110000

女性压力性尿失禁 Meta分析 中药治疗 有效性 安全性

辽宁省科学技术计划项目全国中医药创新骨干人才培训项目辽宁省第一批中医优秀人才培养项目

2014020052国中医药办人教函201991号辽卫办发202129号

2024

中医临床研究
中华中医药学会

中医临床研究

影响因子:0.839
ISSN:1674-7860
年,卷(期):2024.16(21)